PERTH, Australia – After nearly 40 years, New Zealand is preparing new legislation to regulate drugs and devices that would replace the Medicines Act 1981.
BRISBANE, Australia – Australian researchers are using artificial intelligence (AI) to diagnose medical conditions ranging from breast cancer to post-traumatic stress disorder (PTSD) more quickly than ever before.
BRISBANE, Australia – Australian researchers are using artificial intelligence (AI) to diagnose medical conditions ranging from breast cancer to post-traumatic stress disorder (PTSD) more quickly than ever before.
PERTH, Australia – In yet another regional carve-out deal for Starpharma Holdings Ltd., the company has out-licensed rights to its Vivagel BV for bacterial vaginosis (BV) to ITF Pharma for the U.S. market for roughly $101 million.
PERTH, Australia – More money will be deployed in Australia's life sciences sector in the next four or five years than there has ever been, according to Australia's biggest life sciences investor. Brandon Capital Partners manages four life sciences funds with A$531 million (US$374.1 million) under management. Although it's the biggest venture fund in Australia, it's fairly small compared to some of its U.S. peers.
